A Phase 2 Open-Label, Multicenter Study To Evaluate Efficacy And Safety Of Zn-C3 In Adult Women With Recurrent Or Persistent Uterine Serous Carcinoma
Posted Date: Apr 26, 2024
- Investigator: Caroline Billingsley
- Specialties:
- Type of Study: Drug
This is a Phase 2 study to evaluate the clinical activity, safety, pharmacokinetics (PK), and related biomarkers of ZN-c3 in adult women with recurrent or persistent uterine serous carcinoma (USC)
Criteria:
Null
Keywords:
Uterine Serous Carcinoma
For More Information:
Jessica Mullins
NULL
cancer@uchealth.com